Label-free Bacteria Quantification in Blood Plasma by a Bioprinted Microarray Based Interferometric Point-of-Care Device.
Priyanka DeyNuria Fabri-FajaOlalla Calvo-LozanoRoland A TerborgAlexander BelushkinFiliz YesilkoyAnna FàbregaJuan Carlos Ruiz-RodriguezRicard FerrerJuan José González-LópezMaria Carmen EstevezHatice AltugValerio PruneriLaura M LechugaPublished in: ACS sensors (2018)
Existing clinical methods for bacteria detection lack speed, sensitivity, and, importantly, point-of-care (PoC) applicability. Thus, finding ways to push the sensitivity of clinical PoC biosensing technologies is crucial. Here we report a portable PoC device based on lens-free interferometric microscopy (LIM). The device employs high performance nanoplasmonics and custom bioprinted microarrays and is capable of direct label-free bacteria ( E. coli) quantification. With only one-step sample handling we offer a sample-to-data turnaround time of 40 min. Our technology features detection sensitivity of a single bacterial cell both in buffer and in diluted blood plasma and is intrinsically limited by the number of cells present in the detection volume. When employed in a hospital setting, the device has enabled accurate categorization of sepsis patients (infectious SIRS) from control groups (healthy individuals and noninfectious SIRS patients) without false positives/negatives. User-friendly on-site bacterial clinical diagnosis can thus become a reality.
Keyphrases
- label free
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- prognostic factors
- escherichia coli
- acute kidney injury
- healthcare
- high resolution
- loop mediated isothermal amplification
- emergency department
- high throughput
- machine learning
- induced apoptosis
- big data
- adverse drug
- oxidative stress
- optical coherence tomography
- cell proliferation
- septic shock
- high speed